A brief overview
PT Aventis Pharma (“Sanofi Indonesia”) officially became part of PT Kalbe Farma Tbk on November 30, 2022, and duly underwent a change of name to PT Kalventis Sinergi Farma (“Kalventis”). Previously, Sanofi Indonesia was an affiliate of Sanofi S.A. based in France.
​
Our company has undergone many changes during more than seven decades in business. This latest step is intended to ensure sustainable access to our quality medicines and vaccines to improve the health of the Indonesian public.
High-quality Manufacturing Facility
Our manufacturing facility or factory are GMP (Good Manufacturing Practice) certified, halal certified, and the ASEAN FDAs’ registered supplier.
Apart from serving the domestic market, our factories also meet the needs of countries in Southeast Asia, Hong Kong, and South Korea.
Powered by the excellent Talents
As an integrated pharmaceutical company, we are supported by employees with various expertise, experienced in their fields, and uphold integrity.
​
We are committed to maintaining excellence and reliability. Among the ways we achieve this are through meeting comprehensive healthcare needs, ranging from health promotion, prevention, management, to treatment and recovery, with a particular focus on therapeutic areas such as diabetes, vaccines, cardiovascular disorders, and oncology.
Our Journey
Calventis Milestones
